investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

Matthew L. Meyerson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Matthew L. Meyerson

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Christopher S Garris

The Role of Driver Mutations in Lung Cancer Response to Anti-PD-1 Therapy

Trachea, bronchus and lung

Yves Pommier

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

Trachea, bronchus and lung

Hugo Aerts

Genotype and Imaging Phenotype Biomarkers in Lung Cancer

Trachea, bronchus and lung

Curtis Harris

p53, Aging, and Cancer

Trachea, bronchus and lung

Hui-Kuan Lin

Regulation of Akt Signaling Activation by Polyubiquitination

Trachea, bronchus and lung

Pathology

Nathanael Schiander Gray

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Trachea, bronchus and lung

Sherry L Emery

Tobacco Control in a Rapidly Changing Media Environment

Trachea, bronchus and lung

Peter S Hammerman

Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung Cancer

Trachea, bronchus and lung

Dieter Haemmerich

In vivo Derived in Silico Model for DDS Optimization

Trachea, bronchus and lung